Status | Study |
RECRUITING |
Study Name: Post Marketing Surveillance Study for ADYNOVATE in South Korea Condition: Hemophilia A Date: 2019-01-29 Interventions: Pegylated recombinant human factor VIII |
Recruiting |
Study Name: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Condition: Hemophilia A Date: 2016-07-26 Interventions: Drug: Emicizumab Participants will receive emicizumab prophylaxis at the specified dose subcutaneously u |
Completed |
Study Name: Comparison of Different Prophylaxis Regimens for Moderate to Severe Hemophilia A Pediatric Patients Condition: Hemophilia A Date: 2016-03-30 Interventions: Drug: FVIII FVIII concentratio |
Completed |
Study Name: Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A Condition: Severe Haemophilia A Date: 2016-02-18 Interventions: Drug: Pharmacokinetic based dosage change Pharmacokinetic based dosing of factor VIII prophylaxis treatm |
Active, not recruiting |
Study Name: PK Driven Prophylaxis for Hemophilia A Condition: Hemophilia A Date: 2015-12-08 Interventions: Device: MyPKFiT Adjustment of the treatment dose using a decision support software according to the PK v |
Recruiting |
Study Name: Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A." Condition: Hemophilia A Date: 2015-10-20 Interventions: Drug: Recombinant Factor VIII (Kogenate FS, BAY14-2222) |
Enrolling by invitation |
Study Name: Platelet Function in Patients With Hemophilia A Condition: Hemophilia A Date: 2014-03-19 |
COMPLETED |
Study Name: ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD) Condition: Hemophilia A Date: 2014-03-03 Interventions: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method |
Recruiting |
Study Name: Multicentre, Non-controlled, Prospective, Post-Marketing Safety Study Following Long-Term Prophylactic OptivateTreatment in Subjects With Severe Haemophilia A Condition: Haemophilia A Date: 2013-03-13 Interventions: Biological: Optivate 500IU |
Completed |
Study Name: Inhibitor Development in Patients With Hemophilia A Undergoing Surgery Condition: Hemophilia A Date: 2012-04-04 |